2011Lishizhen Medicine and Materia Medica ResearchRequires access

Antiviral Activity of Epigallocatechin Gallate against Coxsackie Virus in vitro

Yang Zhan-qiu

Open publisher page 0 citations

Abstract

Objective To investigate the antiviral activity of epigallocatechin gallate(EGCG) against Coxsackievirus B3(CVB3) in vitro.Methods Cell culture technique was used in HEp-2 cells.The inhibition of the virus-induced cytopathic effect(CPE) was scored by light microscope and measured by MTT assay.The antiviral mechanism of EGCG was studied by changing the ways of drug administration.The therapeutic index(TI=TC50/IC50) was utilized as a comprehensive criterion to evaluate the antiviral activity of EGCG.Results EGCG showed inhibitory activity against CVB3 at high concentration when added before viral infection,while displayed significant antiviral activity against CVB3 when added during or after viral infection,with TIs of 8.7 and 15.3,respectively.With the increase of drug dose,the degree of CPE decreased correspondingly,whereas viral inhibitory rate increased.Conclusion EGCG has potent antiviral activity against CVB3 through several mechanisms.

About this research paper

What this paper is about

Objective To investigate the antiviral activity of epigallocatechin gallate(EGCG) against Coxsackievirus B3(CVB3) in vitro.Methods Cell culture technique was used in HEp-2 cells.The inhibition of the virus-induced cytopathic effect(CPE) was scored by light microscope and measured by MTT assay.The antiviral mechanism of EGCG was studied by changing the ways of drug administration.The therapeutic index(TI=TC50/IC50) was utilized as a comprehensive criterion to evaluate the antiviral activity of EGCG.Results EGCG showed inhibitory activity against CVB3 at high concentration when added before viral infection,while displayed significant antiviral activity against CVB3 when added during or after viral infection,with TIs of 8.7 and 15.3,respectively.With the increase of drug dose,the degree of CPE decreased correspondingly,whereas viral inhibitory rate increased.Conclusion EGCG has potent antiviral activity against CVB3 through several mechanisms.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the antiviral activity of epigallocatechin gallate(EGCG) against Coxsackievirus B3(CVB3) in vitro.Methods Cell culture technique was used in HEp-2 cells.The inhibition of the virus-induced cytopathic effect(CPE) was scored by light microscope and measured by MTT assay.The antiviral mechanism of EGCG was studied by changing the ways of drug administration.The therapeutic index(TI=TC50/IC50) was utilized as a comprehensive criterion to evaluate the antiviral activity of EGCG.Results EGCG showed inhibitory activity against CVB3 at high concentration when added before viral infection,while displayed significant antiviral activity against CVB3 when added during or after viral infection,with TIs of 8.7 and 15.3,respectively.With the increase of drug dose,the degree of CPE decreased correspondingly,whereas viral inhibitory rate increased.Conclusion EGCG has potent antiviral activity against CVB3 through several mechanisms.

Key concepts: Cytopathic effect, In vitro, IC50, Epigallocatechin gallate, Coxsackievirus, Virus, MTT assay, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Antiviral Activity of Epigallocatechin Gallate against Coxsackie Virus in vitro — Research Paper | ScholarLens